Effects of neonatal fentanyl on late adolescent opioid-mediated behavior

Cynthia A Crawford1, Jordan A Taylor1, Ginny I Park1

  • 1Department of Psychology, California State University, San Bernardino, San Bernardino, CA, United States.

Insights

Neonatal fentanyl exposure in rats impacts long-term opioid sensitivity and behavior. Brief early fentanyl exposure altered pain responses and suggested females may be more susceptible to opioid abuse.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Increasing synthetic opioid use in women of childbearing age poses risks to infants.
  • Limited research exists on the long-term effects of high-potency synthetic opioids like fentanyl.
  • Fentanyl exposure during critical developmental periods may have lasting consequences.

Purpose of the Study:

  • To assess the long-term effects of early neonatal fentanyl exposure on adolescent behavior in rats.
  • To investigate alterations in oral fentanyl self-administration and opioid-mediated thermal antinociception.

Main Methods:

  • Rat pups were exposed to fentanyl (0, 10, or 100 μg/kg) from postnatal day 4 to 9.
  • Adolescent rats (PD 40) underwent fentanyl self-administration training.
  • Thermal antinociception was tested in adult rats (PD 60) using morphine or U50,488.

Main Results:

  • Early fentanyl exposure did not significantly alter fentanyl intake or self-administration behavior.
  • Neonatal fentanyl exposure altered thermal antinociception in both sexes.
  • Fentanyl pre-treatment affected baseline pain sensitivity and morphine-induced antinociception.

Conclusions:

  • Brief early fentanyl exposure can lead to persistent alterations in mu-opioid-mediated behaviors.
  • The study suggests potential sex differences in susceptibility to fentanyl's long-term effects.
  • Findings highlight the need for further research into developmental opioid exposure impacts.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
366
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
593
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
705
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
316
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.3K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
177